Abstract
Twenty patients with skin and soft-tissue infections were treated with parenteral cefonicid. Cultures obtained in cellulitis cases from an aspirate of a leading edge of inflammation were positive in 42% of these patients. Pathogens isolated were Staphylococcus aureus (six strains), Proteus mirabilis (one strain), and Streptococcus agalactiae. Adverse effects were pain on intramuscular injection (two patients), rash (one patient), and positive Coombs test (one patient). All side effects were mild and none required discontinuing antibiotic therapy. A single treatment failure occurred in a patient with an undrained perirectal abscess. Cefonicid may be a useful drug in the treatment of skin and soft-tissue infections. The long half-life of cefonicid (4.8 h) is a valuable advantage and may facilitate patient compliance and convenience.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Actor P., Uri J. V., Zajac I., Guarini J. R., Phillips L., Pitkin D. H., Berges D. A., Dunn G. L., Hoover J. R., Weisbach J. A. SK&F 75073, new parenteral broad-spectrum cephalosporin with high and prolonged serum levels. Antimicrob Agents Chemother. 1978 May;13(5):784–790. doi: 10.1128/aac.13.5.784. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
- Bayer A. S., Morrison J. O., Kim K. S. Comparative in vitro bactericidal activity of cefonicid, ceftizoxime, and penicillin against group B streptococci. Antimicrob Agents Chemother. 1982 Feb;21(2):344–346. doi: 10.1128/aac.21.2.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Duncan W. C., McBride M. E. Single-dose treatment of uncomplicated gonococcal urethritis: a comparison of cefonicid and penicillin. Sex Transm Dis. 1982 Apr-Jun;9(2):93–95. doi: 10.1097/00007435-198204000-00008. [DOI] [PubMed] [Google Scholar]
- Geddes A. M., Schnurr L. P., Ball A. P., McGhie D., Brookes G. R., Wise R., Andrews J. Cefoxitin: a hospital study. Br Med J. 1977 Apr 30;1(6069):1126–1128. doi: 10.1136/bmj.1.6069.1126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Grappel S. F., Guarini J. R., Actor P., Weisbach J. A. Correlation of agar-disc-diffusion tests with minimum inhibitory concentrations of cefonicid (SK&F 75073) and cephalothin. J Antibiot (Tokyo) 1980 Jan;33(1):85–87. doi: 10.7164/antibiotics.33.85. [DOI] [PubMed] [Google Scholar]
- Molthan L., Reidenberg M. M., Eichman M. F. Positive direct Coombs tests due to cephalothin. N Engl J Med. 1967 Jul 20;277(3):123–125. doi: 10.1056/NEJM196707202770303. [DOI] [PubMed] [Google Scholar]
- Pitkin D., Dubb J., Actor P., Alexander F., Ehrlich S., Familiar R., Stote R. Kinetics and renal handling of cefonicid. Clin Pharmacol Ther. 1981 Nov;30(5):587–593. doi: 10.1038/clpt.1981.208. [DOI] [PubMed] [Google Scholar]
- Reimer L. G., Stratton C. W., Reller L. B. Minimum inhibitory and bactericidal concentrations of 44 antimicrobial agents against three standard control strains in broth with and without human serum. Antimicrob Agents Chemother. 1981 Jun;19(6):1050–1055. doi: 10.1128/aac.19.6.1050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ries K., Levison M. E., Kaye D. Clinical and in vitro evaluation of cefazolin, a new cephalosporin antibiotic. Antimicrob Agents Chemother. 1973 Feb;3(2):168–174. doi: 10.1128/aac.3.2.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wallace R. J., Jr, Niefield S. L., Waters S., Waters B., Awe R. J., Wiss K., Martin R. R., Greenberg S. B. Comparative trial of cefonicid and cefamandole in the therapy of community-acquired pneumonia. Antimicrob Agents Chemother. 1982 Feb;21(2):231–235. doi: 10.1128/aac.21.2.231. [DOI] [PMC free article] [PubMed] [Google Scholar]